IMAST 2025 Abstract and Education Submissions

Support Form

Important Dates:

• Abstract Submission Dates:  July 1 -  October 1, 2024, 11:59 PM EDT (US)
• Abstract Acceptance Notification via email: December 10, 2024*
• Abstract Presenter Acceptance Deadline: January 7, 2025*
• Meeting Dates: April 2-5, 2025

*Dates are subject to change.




SRS Membership
Abstracts can be submitted by SRS Members and non-members.

Meeting Theme
The theme for the 2025 IMAST meeting is “Changing Practice with New Technologies”

Abstract Categories
Abstract submission to IMAST must fit into one of the following categories to be considered for presentation.

*New Category for IMAST 2025: AI & Machine Learning

Abstracts eligible for this category will describe utilization of artificial intelligence, machine learning, predictive analytics, or wearable technology in the diagnosis, treatment planning, intraoperative guidance, or postoperative care of operative spine pathology.


Categories

• Adolescent Idiopathic Scoliosis	• Degenerative Spinal Conditions
• Adult Spinal Deformity	• Early Onset Scoliosis
• AI & Machine Learning*	• Kyphotic Deformities
• Basic Science, Biomechanics/Genetics	• Neuromuscular and Congenital Scoliosis
• Cervical Spine: Deformity, Degenerative	• Quality/Safety/Value/Complications
• Complex (Spondylolisthesis, Tumor, Trauma, etc.)

Authors can choose optional sub-categories to further classify their topic. More than one sub-category can be selected:

Sub-Categories

• Minimally Invasive	• Novel Technique
• Motion Preservation	• Complications

Abstract Submission Instructions:

• Please login to submit your abstract here
  • If you have not submitted a proposal to SRS before or submitted one prior to 2020, you will need to create a new account
• Abstracts are limited to a maximum of 2,500 characters
  • Characters in the abstract title, body and table/image caption will be counted (including spaces) 
  • Characters in the author and institution listing will not be counted
• For each co-author listed, you will need:
  • Full name
  • Designation/degree
  • Email (please ensure to double check all email addresses entered)
  • Country
  • Institution/affiliation
• Limit of one graph, figure or table, max, for each submitted abstract.
• Submitters may revisit the site as often as necessary to edit the submission (finalized or not) at any time before the submission deadline.
• No changes can be made to the abstract text after the submission deadline.

Please note: In order to successfully receive emails regarding your submission, you must add '@owpm1.com' as a safe sender in your email client. Click here for help adding safe senders.


Previous Publication or Presentation
Abstracts which have been published in journals, meeting proceedings, or other publications, as well as those presented at meetings prior to the SRS meeting to which authors wish to submit, are NOT eligible for submission. Only abstracts that have NOT been previously published or presented are eligible for submission.

One-Year Follow-Up Requirement
One-year clinical follow-up is required for abstract submission. The one-year follow up rule does not apply to categories of basic science or biomechanical studies or for topics where one-year follow up is irrelevant such as 30-day re-admission rates.

Disclosure and Licensing Requirement
ALL authors listed on an abstract will be required to submit a:

• Financial relationship disclosure form, including disclosure of ALL financial relationships with ineligible companies*, not only those pertaining to the topic of the abstract, from the past 24 months. 
• FDA Disclosure Form 
• Attestation and Non-exclusive License Form  

If authors on an abstract have not completed these required forms prior to the submission deadline, the abstract will NOT be reviewed or considered for the meeting program.

*An ineligible company is an entity whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services consumed by or on patients. For specific examples of ineligible companies visit accme.org/standards.

Visit this link to disclose: https://owpm1.com/abstracts/IMAST/disclosure

Attendance Requirements
By submitting an abstract to IMAST, abstract authors agree that at least one (1) author will attend the meeting and will be available to present on the date and time assigned. 

In addition, presenting authors are expected to register to attend the meetings for which they are accepted by the deadline set forth in their acceptance notification. Abstracts for which an author is not pre-registered by the dates set forth will automatically be withdrawn from the program.

All travel arrangements are the responsibility of the authors.

Acceptance
All selected authors will be required to respond to a formal invitation by the deadline set forth in their acceptance notification.

Authors without an account AND an updated disclosure cannot be added after the invitation response deadline. No exceptions will be made.

Podium Presentation Cancellation & No-Show Policy
Authors unable to present their paper in-person should inform SRS as soon as possible with a co-author that can attend to present the paper.  If no one is able to attend in person, please inform the SRS Education Team by the date set forth in your acceptance notification, so an alternate paper can be substituted.

Please note: In the case of a "no-show" podium presentation, the presenting author associated with the "no-show" paper will be prohibited from presenting any papers at the next two IMAST meetings.  

E-Point Presentation Cancellation Policy
At least one author or co-author on all E-Point presentations is expected to register to attend the meeting by the deadline set forth in their acceptance notification. 

If this author cancels their registration prior to the meeting, the E-Point presentation may be withdrawn from the program.

CME Review
All presentations must clear a CME review conducted by the SRS CME Committee. Presenters may be required to submit slides for review before the meeting and may be asked to make small or significant changes if a bias issue is found.
Failure to address pertinent CME review issues will result in pulling the presentation from the program and in a one-year ban for abstract presentations and a three-year ban for invited presentations.

Notifications
All submitters will be notified via email of the status of their submission(s) on December 10, 2024.  In the event that you do not receive any notification, please log into the submission site at ANY time to view any recent mail regarding your submissions.

• Please ensure you are using one of the following browsers: Mozilla Firefox 4+, Safari 5+, Chrome 14+, Microsoft Edge.
• Browser back and forward arrows have been disabled.  Users must use the page progress bar located at the top left of each page.
• Inactivity of more than 90 minutes on system pages will result in a session time out. Please save your pages intermittently to avoid loss of data.
• For technical assistance, please email education@srs.org. Support requests are answered within 1 business day.
• In order to successfully receive emails regarding your submission, you must add '@owpm1.com' as a safe sender in your email client. Click here for help adding safe senders.

Questions?

• For further instructions and information on abstract submission, please click here.

• For any further assistance, please contact education@srs.org